Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G de Groot

Showing results (281-290 of 778) with videos related to

Pageof 78
Sort By:
European Journal of Applied Physiology and Occupational Physiology|January 1, 1987
Respiratory valve for oxygen uptake measurements during swimmingH M Toussaint, A Meulemans, G de Groot, et al.
Orthopedics|March 1, 1986
Bipolar implant shoulder arthroplastyA B Swanson, G de Groot Swanson, B K Maupin, et al.
European Journal of Applied Physiology and Occupational Physiology|January 1, 1987
Physiological and biomechanical comparison of roller skating and speed skating on iceR W de Boer, E Vos, W Hutter, et al.
British Journal of Haematology|November 16, 2011
Clot lysis time and the risk of myocardial infarction and ischaemic stroke in young women; results from the RATIO case-control studyBob Siegerink, Mirjam E Meltzer, Philip G de Groot, et al.
Arthritis and Rheumatism|November 6, 2004
Prolonged bleeding time and lupus anticoagulant: a second paradox in the antiphospholipid syndromeR T Urbanus, H B de Laat, P G de Groot, et al.
The Journal of Clinical Investigation|September 1, 1994
Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing bloodH F Heynen, M Lozano Molero, P G de Groot, et al.
Current Opinion in Hematology|April 7, 2007
Fibrinolysis and the risk of venous and arterial thrombosisMirjam E Meltzer, Carine J M Doggen, Philip G de Groot, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2013
Factor VIII concentrate infusion in patients with haemophilia results in decreased von Willebrand factor and ADAMTS-13 activityE R van Bladel, A Tuinenburg, M Roest, et al.
Hypertension (Dallas, Tex. : 1979)|February 1, 1997
Cyclosporin A increases nitric oxide activity in vivoE S Stroes, T F Lüscher, F G de Groot, et al.
British Journal of Haematology|January 28, 2009
Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young menMirjam E Meltzer, Carine J M Doggen, Philip G de Groot, et al.
Pageof 78

Showing results (281-290 of 778) with videos related to

Sort By:
Pageof 78
European Journal of Applied Physiology and Occupational Physiology|January 1, 1987
Respiratory valve for oxygen uptake measurements during swimmingH M Toussaint, A Meulemans, G de Groot, et al.
Orthopedics|March 1, 1986
Bipolar implant shoulder arthroplastyA B Swanson, G de Groot Swanson, B K Maupin, et al.
European Journal of Applied Physiology and Occupational Physiology|January 1, 1987
Physiological and biomechanical comparison of roller skating and speed skating on iceR W de Boer, E Vos, W Hutter, et al.
British Journal of Haematology|November 16, 2011
Clot lysis time and the risk of myocardial infarction and ischaemic stroke in young women; results from the RATIO case-control studyBob Siegerink, Mirjam E Meltzer, Philip G de Groot, et al.
Arthritis and Rheumatism|November 6, 2004
Prolonged bleeding time and lupus anticoagulant: a second paradox in the antiphospholipid syndromeR T Urbanus, H B de Laat, P G de Groot, et al.
The Journal of Clinical Investigation|September 1, 1994
Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing bloodH F Heynen, M Lozano Molero, P G de Groot, et al.
Current Opinion in Hematology|April 7, 2007
Fibrinolysis and the risk of venous and arterial thrombosisMirjam E Meltzer, Carine J M Doggen, Philip G de Groot, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2013
Factor VIII concentrate infusion in patients with haemophilia results in decreased von Willebrand factor and ADAMTS-13 activityE R van Bladel, A Tuinenburg, M Roest, et al.
Hypertension (Dallas, Tex. : 1979)|February 1, 1997
Cyclosporin A increases nitric oxide activity in vivoE S Stroes, T F Lüscher, F G de Groot, et al.
British Journal of Haematology|January 28, 2009
Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young menMirjam E Meltzer, Carine J M Doggen, Philip G de Groot, et al.
Pageof 78